|
The MRC SUPREMO trial (BIG 2-04, EORTC 22051_10052) has recruited its first few patients. Currently over 74 sites in the UK have applied for Site Specific Assessment and over 55 have now obtained their SSA approval. 8 centres have completed their radiotherapy QA questionnaire and are ready to randomise.
EORTC are making good progress with set up and hope to be open to recruitment within the next few months.
Any UK centres that have still to complete the approval process or are having any problems completing the required documentation please get in touch with the trials team and we will help in any way we can.
|